Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Vs. Neostigmine in the PACU for Abdominal Surgeries
NCT04096144Phase 3Not yet recruiting
- Sponsor
- University of South Florida
- Start
- Oct 2019
- Primary completion
- Mar 2020
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by University of South Florida. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT04096144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04096144.